BioLargo, Inc.
BLGO
$0.2088
$0.00412.00%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -10.61% | -15.95% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.61% | -15.95% | |||
| Cost of Revenue | -6.61% | -27.46% | |||
| Gross Profit | -14.97% | 1.63% | |||
| SG&A Expenses | -0.89% | 23.36% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.69% | -2.57% | |||
| Operating Income | -15.22% | -52.31% | |||
| Income Before Tax | -10.91% | -63.40% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.91% | -63.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 6.69% | 37.28% | |||
| Net Income | -13.91% | -88.83% | |||
| EBIT | -15.22% | -52.31% | |||
| EBITDA | -14.47% | -54.81% | |||
| EPS Basic | -11.76% | -88.89% | |||
| Normalized Basic EPS | -16.67% | -140.00% | |||
| EPS Diluted | -11.76% | -88.89% | |||
| Normalized Diluted EPS | -16.67% | -140.00% | |||
| Average Basic Shares Outstanding | 0.02% | 0.24% | |||
| Average Diluted Shares Outstanding | 0.02% | 0.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||